Indication
Thymic Tumors
1 clinical trial
1 product
Product
KC1036Clinical trial
A Single-arm, Open, Multicenter, Phase II Study to Evaluate the Efficacy and Safety of KC1036 in the Patients With Advanced Recurrent or Metastatic Thymic TumorsStatus: Recruiting, Estimated PCD: 2025-02-01